CFTR and ENaC functions in cystic fibrosis

被引:0
作者
Palma, Alejandra G. [1 ]
Kotsias, Basilio A. [1 ]
Marino, Gabriela I. [1 ]
机构
[1] Univ Buenos Aires, IDIM CONICET, Inst Invest Med Alfredo Lanari, Lab Cana Ion, Buenos Aires, DF, Argentina
关键词
cystic fibrosis; CFTR; ENaC; ionic movements; cytoskeleton; TRANSMEMBRANE CONDUCTANCE REGULATOR; GAP-JUNCTION CHANNELS; MUTATIONS; GENE; EXPRESSION; DELTA-F508; TRANSPORT; AMILORIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis is caused by dysfunction or lack of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that has a key role in maintaining ion and water honnoeostasis in different tissues. CFTR is a cyclic AMP-activated Cl- channel found in the apical and basal plasma membrane of airway, intestinal, and exocrine epithelial cells. One of CFTR's primary roles in the lungs is to maintain homoeostasis of the airway surface liquid layer through its function as a chloride channel and its regulation of the epithelial sodium channel ENaC. More than 1900 CFTR mutations have been identified in the cftr gene. The disease is characterized by viscous secretions of the exocrine glands in multiple organs and elevated levels of sweat sodium chloride. In cystic fibrosis, salt and fluid absorption is prevented by the loss of CFTR and ENaC is not appropriately regulated, resulting in increased fluid and sodium resorption from the airways and formation of a contracted viscous surface liquid layer. In the sweat glands both Na+ and Cl- ions are retained in the lumen, causing significant loss of electrolytes during sweating. Thus, elevated sweat NaCl concentration is the basis of the classic pilocarpine-induced sweat test as a diagnostic feature of the disease. Here we discuss the ion movement of Cl- and Na+ ions in two tissues, sweat glands and in the air surface as well as the role of ENaC in the pathogenesis of cystic fibrosis.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
[41]   THE CYSTIC-FIBROSIS GENE - MUTATIONS AND FUNCTION OF THE CFTR PROTEIN [J].
GOOSSENS, M .
ANNALES DE PEDIATRIE, 1991, 38 (09) :591-594
[42]   Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity [J].
Paranjapye, Alekh ;
Ruffin, Manon ;
Harris, Ann ;
Corvol, Harriet .
JOURNAL OF CYSTIC FIBROSIS, 2020, 19 :S10-S14
[43]   Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs [J].
Abu-Arish, Asmahan ;
Pandzic, Elvis ;
Luo, Yishan ;
Sato, Yukiko ;
Turner, Mark J. ;
Wiseman, Paul W. ;
Hanrahan, John W. .
JOURNAL OF CELL SCIENCE, 2022, 135 (05)
[44]   CFTR: cystic fibrosis and beyond [J].
Mall, Marcus A. ;
Hartl, Dominik .
EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) :1042-1054
[45]   Functional Consequences of CFTR Interactions in Cystic Fibrosis [J].
Ramananda, Yashaswini ;
Naren, Anjaparavanda P. ;
Arora, Kavisha .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
[46]   Effects of the serine/threonine kinase SGK1 on the epithelial Na+ channel (ENaC) and CFTR:: Implications for cystic fibrosis [J].
Wagner, CA ;
Ott, M ;
Klingel, K ;
Beck, S ;
Melzig, J ;
Friedrich, B ;
Wild, KN ;
Bröer, S ;
Moschen, I ;
Albers, A ;
Waldegger, S ;
Tümmler, B ;
Egan, ME ;
Geibel, JP ;
Kandolf, R ;
Lang, F .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2001, 11 (04) :209-218
[47]   DETECTION OF CFTR MUTATIONS IN CHILDREN WITH CYSTIC FIBROSIS [J].
Nikiforova, A., I ;
Abramov, D. D. ;
Zobkova, G. Yu ;
Goriainova, A., V ;
Semykin, S. Yu ;
Shubina, J. ;
Donnikov, A. E. ;
Trofimov, D. Yu .
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2018, (03) :34-40
[48]   Antisense oligonucleotides for therapy of cystic fibrosis - Inhition of sodium absorption mediated by ENaC in nasal epithelial cells [J].
Sobczak, K. ;
Bangel-Ruland, N. ;
Semmler, J. ;
Lindemann, H. ;
Heermann, R. ;
Weber, W. -M. .
HNO, 2009, 57 (11) :1106-1112
[49]   Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis [J].
Gonska, T. ;
Ip, W. ;
Turner, D. ;
Han, W. S. ;
Rose, J. ;
Durie, P. ;
Quinton, P. .
THORAX, 2009, 64 (11) :932-938
[50]   Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye [J].
Erdal, Meltem Akgul ;
Buyuksahin, Halime Nayir ;
Sen, Velat ;
Kilinc, Ayse Ayzit ;
Cokugras, Haluk ;
Dogan, Guzide ;
Yilmaz, Asli Imran ;
Unal, Gokcen ;
Serbes, Mahir ;
Altintas, Derya Ufuk ;
Arik, Elif ;
Keskin, Ozlem ;
Ozaslan, Mehmet Mustafa ;
Karcioglu, Oguz ;
Kose, Mehmet ;
Basaran, Abdurrahman Erdem ;
Cakir, Eylul Pinar ;
Canitez, Yakup ;
Ozdemir, Ali ;
Harmanci, Koray ;
Uytun, Salih ;
Polat, Sanem Eryilmaz ;
Hangul, Melih ;
Yuksel, Hasan ;
Ozcan, Gizem ;
Korkmaz, Pervin ;
Kilic, Mehmet ;
Aydin, Zeynep Gokce Gayretli ;
Caltepe, Gonul ;
Can, Demet ;
Dogru, Sibel ;
Ozturk, Gokcen Kartal ;
Suleyman, Ayse ;
Topal, Erdem ;
Ozsezen, Beste ;
Hizal, Mina ;
Demirdogen, Ezgi ;
Ogun, Hamza ;
Borekci, Sermin ;
Yazan, Hakan ;
Sen, Hadice Selimoglu ;
Demir, Ayseguel Dogan ;
Cakir, Erkan ;
Eyuboglu, Tugba Sismanlar ;
Emiralioglu, Nagehan ;
Pekcan, Sevgi ;
Ozcelik, Ugur ;
Dogru, Deniz .
TURKISH JOURNAL OF PEDIATRICS, 2025, 67 (01) :22-30